Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Scandinavian Journal of Work, Environment & Health|August 26, 2003
Prevention of farm injuries in DenmarkKurt Rasmussen, Ole Carstensen, Jens M Lauritsen, et al.Metabolism Open|September 12, 2022
SGLT2 inhibition reduces myocardial oxygen consumptionEsben Søndergaard, Esben S Lauritzen, Katrine M Lauritsen, et al.Endocrine Connections|March 2, 2022
Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetesKatrine M Lauritsen, Jens Hohwü Voigt, Steen Bønløkke Pedersen, et al.Public Health Action|September 23, 2015
Efficient, quality-assured data capture in operational research through innovative use of open-access technologyA M V Kumar, B Naik, D K Guddemane, et al.Diabetes|December 18, 2020
SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover TrialKatrine M Lauritsen, Bent R R Nielsen, Lars P Tolbod, et al.Critical Care (London, England)|October 14, 2011
Collecting core data in severely injured patients using a consensus trauma template: an international multicentre studyKjetil Gorseth Ringdal, Hans Morten Lossius, J Mary Jones, et al.Basic & Clinical Pharmacology & Toxicology|February 27, 2024
Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetesJens Hohwü Voigt, Katrine M Lauritsen, Steen Bønløkke Pedersen, et al.The Journal of Nutrition|August 20, 2023
Dose-Response of Myofibrillar Protein Synthesis To Ingested Whey Protein During Energy Restriction in Overweight Postmenopausal Women: A Randomized, Controlled TrialMads S Larsen, Oliver C Witard, Lars Holm, et al.Pageof 6